Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127706881 | 12770688 | 1 | I | 20160513 | 20160913 | 20160922 | 20160922 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075498 | BRISTOL MYERS SQUIBB | 50.00 | YR | M | Y | 0.00000 | 20160922 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127706881 | 12770688 | 1 | PS | APIXABAN | APIXABAN | 1 | Unknown | U | U | 202155 | |||||||||
| 127706881 | 12770688 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | U | 0 | |||||||||
| 127706881 | 12770688 | 3 | SS | DIAZEPAM. | DIAZEPAM | 1 | Unknown | U | U | 0 | |||||||||
| 127706881 | 12770688 | 4 | SS | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Subcutaneous | U | U | 0 | .2 | ML | SOLUTION FOR INJECTION | ||||||
| 127706881 | 12770688 | 5 | SS | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 5 ML, UNK | U | U | 0 | 5 | ML | SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127706881 | 12770688 | 1 | Product used for unknown indication |
| 127706881 | 12770688 | 2 | Product used for unknown indication |
| 127706881 | 12770688 | 3 | Product used for unknown indication |
| 127706881 | 12770688 | 4 | Product used for unknown indication |
| 127706881 | 12770688 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127706881 | 12770688 | LT |
| 127706881 | 12770688 | OT |
| 127706881 | 12770688 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127706881 | 12770688 | Asthenia | |
| 127706881 | 12770688 | Atrial fibrillation | |
| 127706881 | 12770688 | Back pain | |
| 127706881 | 12770688 | Cardiac failure | |
| 127706881 | 12770688 | Complication associated with device | |
| 127706881 | 12770688 | Delusional disorder, unspecified type | |
| 127706881 | 12770688 | Discomfort | |
| 127706881 | 12770688 | Feeding disorder | |
| 127706881 | 12770688 | General physical condition abnormal | |
| 127706881 | 12770688 | Haemoptysis | |
| 127706881 | 12770688 | Heart rate abnormal | |
| 127706881 | 12770688 | Hepatic failure | |
| 127706881 | 12770688 | Insomnia | |
| 127706881 | 12770688 | Jaundice | |
| 127706881 | 12770688 | Malaise | |
| 127706881 | 12770688 | Monoplegia | |
| 127706881 | 12770688 | Muscle haemorrhage | |
| 127706881 | 12770688 | Neuropathy peripheral | |
| 127706881 | 12770688 | Poor peripheral circulation | |
| 127706881 | 12770688 | Productive cough | |
| 127706881 | 12770688 | Protein total decreased | |
| 127706881 | 12770688 | Pyrexia | |
| 127706881 | 12770688 | Renal failure | |
| 127706881 | 12770688 | Sensory disturbance | |
| 127706881 | 12770688 | Septic rash | |
| 127706881 | 12770688 | Septic shock | |
| 127706881 | 12770688 | Thrombocytopenia | |
| 127706881 | 12770688 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127706881 | 12770688 | 4 | 20160512 | 201607 | 0 | |
| 127706881 | 12770688 | 5 | 20160512 | 201607 | 0 |